Computational dreams and catmint schemes

2026-05-14T11:52:42+01:0019 May 2026|

At the Wellcome Sanger Institute, Xiaotian Liao navigates a world of protein puzzles, global experiences and furry friends, blending curiosity and computation into a journey that stretches far beyond the lab.

Unlocking the genetics of skin cancer

2024-11-12T11:17:26+00:0012 November 2024|

Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.

Prime Editing

2024-05-21T16:19:58+01:0017 July 2023|

Prime editing is the latest technique that enables scientists to alter the DNA of a living cell. It builds on CRISPR-Cas9 technology, and offers the potential to edit human cells to treat genetic diseases.

Human Embryo Editing: science fiction or science fact?

2018-11-29T15:35:59+00:0029 November 2018|

Anna Middleton, Head of the Society and Ethics research group at Wellcome Genome Campus Connecting Science, reports on Prof He Jiankiu's unverified announcement of gene editing the first human embryos that have been born